Results of second transurethral resection for high-grade T1 bladder cancer.

about

Results of second transurethral resection for high-grade T1 bladder cancer.

Item

http://www.wikidata.org/entity/Q36481219

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Results of second transurethral resection for high-grade T1 bladder cancer.

@ast

Results of second transurethral resection for high-grade T1 bladder cancer.

@en

type

Item

label

Results of second transurethral resection for high-grade T1 bladder cancer.

@ast

Results of second transurethral resection for high-grade T1 bladder cancer.

@en

prefLabel

Results of second transurethral resection for high-grade T1 bladder cancer.

@ast

Results of second transurethral resection for high-grade T1 bladder cancer.

@en

P1476

Results of second transurethral resection for high-grade T1 bladder cancer.

@en

P2093

Iku Ninomiya

http://www.w3.org/2001/XMLSchema#string

Katsuyoshi Hashine

http://www.w3.org/2001/XMLSchema#string

Norihiro Teramoto

http://www.w3.org/2001/XMLSchema#string

Tadanori Hosokawa

http://www.w3.org/2001/XMLSchema#string

Takehiro Ide

http://www.w3.org/2001/XMLSchema#string

Takeshi Nakashima

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high

Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review.

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

Recurrence of high-risk bladder cancer: a population-based analysis.

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer.

Watchful waiting versus intravesical BCG therapy for high-grade pT1 bladder cancer with pT0 histology after second transurethral resection: Japan Clinical Oncology Group Study JCOG1019.

P304

10-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0974-7796.163798

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26834394

http://www.w3.org/2001/XMLSchema#string

P932

4719498

http://www.w3.org/2001/XMLSchema#string